Events
ASCO GU 2025: Talazoparib and enzalutamide combination improves survival in some patients with prostate cancer
- RAD51 biomarker could complement next-generation sequencing in personalising prostate cancer treatment
- ASCO GU 2025: ENZA-p combination treatment improves survival for metastatic prostate cancer
- Study establishes link between early side effects from prostate cancer radiation and long-term side effects
Does cannabis have a role in cancer treatment?
Does cannabis have a role in cancer treatment? What does the latest research tell us about optimal use? What are…
Immune cells that fight cancer become exhausted within hours of first encountering tumours – new research
Mary Philip, Vanderbilt University and Michael Rudloff, Vanderbilt University A key function of our immune system is to detect and…








